Solubility Enhancement of Budesonide and Statistical Optimization of Coating Variables for Targeted Drug Delivery

Table 13

Results of stability study of optimized batch HB1 and HB2.

Tested after time	HB1		HB2
	Appearance	Drug content (%) (Mean ± S.D.)	Appearance	Drug content (%) (mean ± S.D.)
0 month	No change	100.18%±2.10	No change	98.7%±1.39
1 month	No change	99.09%±0.63	No change	98.97%±0.74
2 months	No change	98.72%±1.30	No change	99.34%±1.12
3 months	No change	98.12%±0.98	No change	99.87%±1.89